Skip to main content

Table 3 Details of pleural infection by intervention

From: A feasibility randomised trial comparing therapeutic thoracentesis to chest tube insertion for the management of pleural infection: results from the ACTion trial

 

Chest tube (n = 5)

Therapeutic thoracentesis (n = 5)

Total cohort

(n = 10)

Community acquired (%)

5 (100%)

5 (100%)

10 (100%)

Mean duration of symptoms in weeks (range)

3 (1–6)

3 (1–8)

3 (1–8)

Right sided

3 (60%)

0 (0%)

3 (30%)

Size on chest radiograph

 Small (< 25%)

0

2

2

 Moderate (25–49%)

4

3

7

 Large (≥ 50%)

1

0

1

Degree of complexity on pleural ultrasound

 None

0

2

2

 Mild

4

3

7

 Moderate

1

0

1

 Heavy

0

0

0

Pleural thickening on ultrasound

4

3

7

Pleural fluid analysis (mean, SD)

pH

7.0 (0.2)

7.0 (0.1)

7.0 (0.2)

LDH (iu/L)

1655 (1886)

1357 (608)

1506 (1330)

Glucose (mmol/L)

0.4 (1.2)

0.7 (1.4)

0.5 (1.2)

Gram stain positive

0

0

0

Culture positive

1- Staphylococcus Intermedius

1- Staphylococcus aureus

0

2

  1. SD Standard Deviation, CRP C Reactive Protein, LDH Lactate Dehydrogenase